Vertex Pharmaceuticals Inc (VRTX) Monthly Backtest Results

The data points on this monthly chart show the results of using the 10 Month SMA Double Cross strategy on this stock. Read about this strategy here. This is a long term investment strategy designed to catch major bull runs in stocks and indices then exit before the worst of a serious drawdown. It tends to work better with securites that are prone to forming valuation bubbles. To view shorter term swing trading entry signals for this stock then go here.

Key: change_history : trade entry change_history : profitable trade exit change_history : breakeven trade exit (5% loss to 5% profit) change_history : losing trade (greater than 5% loss) show_chart : 10 month simple moving average (SMA)
Hover your mouse over the labels to view more details of each trade.
*Transaction costs, taxes and dividends are excluded from these calculations. Past performance may not necessarily be a reliable guide to future performance.

 

Backtest Summary

This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.

Entry Date Exit Date Profit or Loss CAGR
03 March 2025 02 June 2025 -7.74% -27.62%
01 May 2023 02 January 2025 18.05% 10.42%
01 February 2022 01 March 2023 18.90% 17.44%
02 December 2019 02 November 2020 -5.68% -6.15%
01 March 2019 01 May 2019 -10.66% -49.07%
01 August 2018 02 January 2019 -7.88% -17.79%
01 March 2017 01 June 2018 68.53% 51.72%
01 September 2016 03 October 2016 -8.71% -64.64%
Total Return 64.80%

 

The monthly data for Vertex Pharmaceuticals Inc (exchange: XNAS symbol: VRTX) was last updated 27 Dec 2025 05:20. Data for this stock is available from 01 Dec 2015 - 26 Dec 2025.